UK-432,097

UK-432,097
Names
	IUPAC name 6-(2,2-diphenylethylamino)-9-((2R,3R,4S,5S)-5-(ethylcarbamoyl)-3,4-dihydroxytetrahydrofuran-2-yl)-N-(2-(3-(1-(pyridin-2-yl)piperidin-4-yl)ureido)ethyl)-9H-purine-2-carboxamide
Identifiers
CAS Number	380221-63-6
Abbreviations	UK-432,097
ChemSpider	8009243
Jmol 3D model	Interactive image; Interactive image
PubChem	9833519
	InChI InChI=1S/C40H47N11O6/c1-2-41-37(54)33-31(52)32(53)39(57-33)51-24-46-30-34(45-23-28(25-11-5-3-6-12-25)26-13-7-4-8-14-26)48-35(49-36(30)51)38(55)43-19-20-44-40(56)47-27-16-21-50(22-17-27)29-15-9-10-18-42-29/h3-15,18,24,27-28,31-33,39,52-53H,2,16-17,19-23H2,1H3,(H,41,54)(H,43,55)(H2,44,47,56)(H,45,48,49)/t31-,32+,33-,39+/m0/s1 Key: ZOTHAEBAWXWVID-HXEFRTELSA-N ;
	SMILES O=C(NCC)[C@H]([C@@H](O)[C@H]1O)O[C@H]1N2C=NC3=C(NCC(C4=CC=CC=C4)C5=CC=CC=C5)N=C(C(NCCNC(NC6CCN(C7=NC=CC=C7)CC6)=O)=O)N=C32 ; O=C(NC2CCN(c1ncccc1)CC2)NCCNC(=O)c5nc3c(ncn3[C@@H]4O[C@H](C(=O)NCC)[C@@H](O)[C@H]4O)c(n5)NCC(c6ccccc6)c7ccccc7 ;
Properties
Chemical formula	C40H47N11O6
Molar mass	777.89 g·mol−1
	Except where otherwise noted, data are given for materials in their standard state (at 25 °C [77 °F], 100 kPa).
	verify (what is ?)
	Infobox references

UK-432,097 is a drug developed by Pfizer for the treatment of chronic obstructive pulmonary disease, which acts as a potent and selective agonist of the adenosine A_2A receptor.^[1] It was discontinued from clinical trials following poor efficacy results,^[2] but its high selectivity has made it useful for detailed mapping of the internal structure of the A_2A receptor.^[3]

References

↑ Lua error in package.lua at line 80: module 'strict' not found.
↑ Safety And Efficacy Of UK-432,097 In Chronic Obstructive Pulmonary Disease. ClinicalTrials.gov
↑ Lua error in package.lua at line 80: module 'strict' not found.

This drug article relating to the respiratory system is a stub. You can help Wikipedia by expanding it.

This article about an organic compound is a stub. You can help Wikipedia by expanding it.